Keurig Dr Pepper (NASDAQ:KDP) Stock Price Target Raised at TD Cowen

Keurig Dr Pepper (NASDAQ:KDP) had its price target lifted by TD Cowen from $33.00 to $35.00 in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a hold rating on the stock.

Other equities analysts have also recently issued research reports about the company. UBS Group raised their target price on Keurig Dr Pepper from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Friday, August 7th. Sanford C. Bernstein set a $39.00 target price on Keurig Dr Pepper in a research report on Wednesday, July 8th. Evercore upped their price target on Keurig Dr Pepper from $30.00 to $32.00 in a research note on Thursday, October 8th. Morgan Stanley lifted their price objective on shares of Keurig Dr Pepper from $38.00 to $40.00 and gave the stock an “overweight” rating in a research note on Wednesday. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Keurig Dr Pepper in a report on Friday, August 7th. Ten investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $37.12.

Keurig Dr Pepper Stock Performance

KDP stock opened at $36.79 on Wednesday. Keurig Dr Pepper has a twelve month low of $24.88 and a twelve month high of $37.31. The company has a quick ratio of 0.28, a current ratio of 0.52 and a debt-to-equity ratio of 0.73. The company has a market cap of $50.06 billion, a P/E ratio of 33.75, a price-to-earnings-growth ratio of 1.65 and a beta of 0.35. The business’s fifty day moving average is $32.68 and its 200-day moving average is $30.11.

Keurig Dr Pepper (NASDAQ:KDP) last announced its quarterly earnings data on Tuesday, November 3rd. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.04. Keurig Dr Pepper had a return on equity of 11.27% and a net margin of 7.12%. The business had revenue of $7.34 billion during the quarter, compared to analysts’ expectations of $7.33 billion. During the same period in the previous year, the firm earned $0.54 earnings per share. The firm’s quarterly revenue was up 70.6% compared to the same quarter last year. Equities research analysts forecast that Keurig Dr Pepper will post 2.30 EPS for the current year.

Keurig Dr Pepper Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 9th. Shareholders of record on Monday, September 28th were issued a dividend of $0.23 per share. The ex-dividend date was Monday, September 28th. This represents a $0.92 annualized dividend and a yield of 2.5%. Keurig Dr Pepper’s payout ratio is currently 92.93%.

Insiders Place Their Bets

In other Keurig Dr Pepper news, Director Aaron Alt bought 7,862 shares of the firm’s stock in a transaction on Tuesday, August 25th. The stock was purchased at an average cost of $31.83 per share, with a total value of $250,247.46. Following the completion of the purchase, the director owned 7,862 shares in the company, valued at approximately $250,247.46. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Angela Stephens sold 9,500 shares of the stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $32.70, for a total value of $310,650.00. Following the completion of the sale, the vice president owned 55,786 shares of the company’s stock, valued at $1,824,202.20. This trade represents a 14.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.34% of the company’s stock.

Hedge Funds Weigh In On Keurig Dr Pepper

Several institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. bought a new position in Keurig Dr Pepper in the second quarter valued at approximately $4,697,645,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in shares of Keurig Dr Pepper in the second quarter valued at approximately $767,105,000. Dimensional Fund Advisors LP increased its position in shares of Keurig Dr Pepper by 1.1% during the first quarter. Dimensional Fund Advisors LP now owns 9,585,791 shares of the company’s stock worth $252,408,000 after acquiring an additional 103,505 shares in the last quarter. Bank of America Corp DE bought a new stake in shares of Keurig Dr Pepper during the second quarter worth $281,503,000. Finally, Legal & General Group Plc bought a new stake in shares of Keurig Dr Pepper during the second quarter worth $269,336,000. 93.99% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Keurig Dr Pepper

Here are the key news stories impacting Keurig Dr Pepper this week:

• Positive Sentiment: KDP reported third-quarter adjusted earnings of $0.66 per share, above analyst expectations, while revenue of $7.34 billion was roughly in line with or slightly ahead of estimates. Earnings rose from $0.54 per share a year earlier, and the company reaffirmed its 2026 outlook. Keurig Dr Pepper Q3 results and guidance
• Positive Sentiment: Analysts raised targets: UBS to $42 with a Buy rating, JPMorgan to $41 with an Overweight rating, and Morgan Stanley to $40 with an Overweight rating. Piper Sandler also lifted its target to $41. These revisions suggest several firms see further upside. UBS recommendations
• Positive Sentiment: Beverage growth and acquired JDE Peet’s contributed to strong reported sales growth; coverage also noted KDP’s energy-drink share surpassed 10%. This supports the company’s growth story beyond its legacy coffee business. Long-term investor takeaways
• Neutral Sentiment: KDP expects 2026 net sales of $25.9 billion to $26.4 billion and is planning to separate its businesses in early 2027. The separation could reshape the company, though its eventual impact is uncertain. Sales outlook and planned separation
• Negative Sentiment: Management flagged a challenging U.S. coffee environment, with consumers trading down expected to weigh on fourth-quarter coffee profitability. TD Cowen raised its target to $35 but maintained a Hold rating, implying a more cautious outlook. Coffee profit outlook

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.

The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.